Expression Table for this CRE
| CNhs14417 | 293SLAM rinderpest infection, 24hr, biol_rep2 | 14.0 |
| CNhs12060 | Skeletal Muscle Cells, donor6 | 6.8 |
| CNhs13839 | iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2 | 4.7 |
| CNhs13831 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 4.7 |
| CNhs13845 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 4.4 |
| CNhs12872 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12) | 3.8 |
| CNhs13841 | iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 3.3 |
| CNhs13844 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 3.1 |
| CNhs12061 | Fibroblast - Cardiac, donor6 | 2.8 |
| CNhs12698 | K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2 | 2.7 |
| CNhs13837 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1 | 2.2 |
| CNhs13840 | iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2 | 2.1 |
| CNhs13835 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1 | 1.8 |
| CNhs14428 | COBL-a rinderpest infection, 24hr, biol_rep1 | 1.6 |
| CNhs14525 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3 | 1.6 |
| CNhs12052 | Fibroblast - Dermal, donor4 | 1.3 |
| CNhs14129 | Fibroblast - Gingival, donor6 (control) | 1.3 |
| CNhs13332 | Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3) | 1.3 |
| CNhs12502 | amniotic membrane cells, donor1 | 1.3 |
| CNhs14138 | bronchioalveolar carcinoma cell line:NCI-H650 | 1.2 |
| CNhs13836 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1 | 1.1 |
| CNhs12317 | parietal lobe, adult, donor10252 | 1.1 |
| CNhs13646 | Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h) | 1.0 |
| CNhs12896 | H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6) | 1.0 |
| CNhs12380 | chorionic membrane cells, donor3 | 1.0 |
| CNhs13492 | CD14+ monocytes - treated with Group A streptococci, donor3 | 1.0 |
| CNhs12797 | K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3 | 0.9 |
| CNhs13833 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1 | 0.9 |
| CNhs11983 | Skeletal Muscle Cells, donor2 | 0.9 |
| CNhs11872 | thyroid carcinoma cell line:TCO-1 | 0.9 |
| CNhs14084 | thalamus, newborn, donor10223 | 0.8 |
| CNhs12480 | MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2 | 0.8 |
| CNhs11934 | myelodysplastic syndrome cell line:SKM-1 | 0.7 |
| CNhs14496 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3 | 0.7 |
| CNhs12925 | Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1) | 0.7 |
| CNhs14139 | thymic carcinoma cell line:Ty-82 | 0.7 |
| CNhs12491 | MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2 | 0.7 |
| CNhs12498 | Fibroblast - Cardiac, donor1 | 0.7 |
| CNhs13549 | CD14+CD16+ Monocytes, donor3 | 0.7 |
| CNhs14128 | Fibroblast - Gingival, donor6 (aggressive periodontitis) | 0.7 |
| CNhs12467 | K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1 | 0.6 |
| CNhs13540 | CD14+CD16- Monocytes, donor3 | 0.6 |
| CNhs12229 | pituitary gland, adult, donor10252 | 0.6 |
| CNhs12398 | Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction) | 0.6 |
| CNhs12488 | MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2 | 0.6 |
| CNhs12045 | Smooth Muscle Cells - Coronary Artery, donor3 | 0.6 |
| CNhs14586 | Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1 | 0.6 |
| CNhs12494 | Adipocyte - subcutaneous, donor1 | 0.6 |
| CNhs12949 | H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12) | 0.5 |
| CNhs13543 | CD14+ monocytes - treated with BCG, donor3 | 0.5 |